Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 1467 entries
View as:

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01353469 Org: User:
Start: 05/31/11 End: 11/30/12 Due: 11/30/13

An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01854047 Org: User:
Start: 06/30/13 End: 04/30/15 Due: 04/30/16

Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01082549 Org: User:
Start: 03/31/10 End: 04/30/13 Due: 04/30/14

Open Label Study of Long Term Safety Evaluation of Alirocumab

Phase: N/A Priority: Normal
NCT ID: NCT01954394 Org: User:
Start: 12/17/13 End: 06/30/17 Due: 06/30/18

Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

Phase: N/A Priority: Normal
NCT ID: NCT03874715 Org: User:
Start: 03/11/19 End: 07/08/20 Due: 07/08/21

Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting

Phase: N/A Priority: Normal
NCT ID: NCT01079364 Org: User:
Start: 01/31/10 End: 07/31/12 Due: 07/31/13

Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00263003 Org: User:
Start: 06/30/05 End: - Due: -

Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00754689 Org: User:
Start: 09/30/08 End: 11/30/08 Due: 11/30/09

Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00353080 Org: User:
Start: 12/31/02 End: 04/30/05 Due: 04/30/06

Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04294459 Org: User:
Start: 06/18/20 End: 05/02/22 Due: 05/02/23

A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)

Phase: N/A Priority: Normal
NCT ID: NCT04106544 Org: User:
Start: 09/27/19 End: 05/15/23 Due: 05/15/24

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01683266 Org: User:
Start: 09/30/12 End: 03/31/14 Due: 03/31/15

An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

Phase: N/A Priority: Normal
NCT ID: NCT00250627 Org: User:
Start: 12/31/04 End: 12/31/06 Due: 12/31/07

Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01497964 Org: User:
Start: 12/31/11 End: 05/31/13 Due: 05/31/14

An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01130259 Org: User:
Start: - End: - Due: -

Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00664417 Org: User:
Start: 04/30/08 End: 08/31/10 Due: 08/31/11

Alfuzosin Versus Placebo in Acute Urinary Retention

Phase: N/A Priority: Normal
NCT ID: NCT00453908 Org: User:
Start: 05/31/04 End: - Due: -

Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT06665308 Org: User:
Start: 01/13/25 End: 09/12/25 Due: 09/12/26

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

Phase: N/A Priority: Normal
NCT ID: NCT04456673 Org: User:
Start: 07/06/20 End: 05/27/24 Due: 05/27/25

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)

Phase: N/A Priority: Normal
NCT ID: NCT00249873 Org: User:
Start: 06/30/03 End: 03/31/09 Due: 03/31/10

Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00439634 Org: User:
Start: 02/28/07 End: 09/30/09 Due: 09/30/10

Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05976386 Org: User:
Start: 06/08/21 End: 09/24/21 Due: 09/24/22

Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00921661 Org: User:
Start: 06/30/09 End: 06/30/12 Due: 06/30/13

Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral

Phase: N/A Priority: Normal
NCT ID: NCT00933504 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)

Phase: N/A Priority: Normal
NCT ID: NCT03620747 Org: User:
Start: 08/30/18 End: 02/18/22 Due: 02/18/23